Raymond James & Associates’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$5.66M Buy
116,677
+1,958
+2% +$85.9K ﹤0.01% 1573
2024
Q2
$4.59M Buy
114,719
+16,574
+17% +$687K ﹤0.01% 1638
2024
Q1
$4.31M Buy
98,145
+5,486
+6% +$283K ﹤0.01% 1693
2023
Q4
$5.73M Buy
92,659
+39,916
+76% +$2.1M ﹤0.01% 1449
2023
Q3
$2.43M Sell
52,743
-2,425
-4% -$132K ﹤0.01% 1901
2023
Q2
$3.17M Buy
55,168
+31,607
+134% +$1.4M ﹤0.01% 1783
2023
Q1
$884K Buy
23,561
+483
+2% +$15.8K ﹤0.01% 2525
2022
Q4
$647K Sell
23,078
-2,834
-11% -$82.3K ﹤0.01% 2710
2022
Q3
$728K Buy
25,912
+7,629
+42% +$249K ﹤0.01% 2586
2022
Q2
$636K Buy
18,283
+1,591
+10% +$56.8K ﹤0.01% 2755
2022
Q1
$599K Buy
+16,692
New +$473K ﹤0.01% 2958
2021
Q1
Sell
-13,666
Closed -$275K 3994
2020
Q4
$275K Sell
13,666
-1,481
-10% -$28.8K ﹤0.01% 3174
2020
Q3
$284K Buy
15,147
+1,470
+11% +$29.6K ﹤0.01% 2990
2020
Q2
$307K Buy
+13,677
New +$250K ﹤0.01% 2907
2019
Q3
Sell
-38,231
Closed -$807K 3608
2019
Q2
$807K Buy
38,231
+1,944
+5% +$40.6K ﹤0.01% 2348
2019
Q1
$741K Sell
36,287
-2,873
-7% -$64.4K ﹤0.01% 2386
2018
Q4
$779K Sell
39,160
-452
-1% -$8.91K ﹤0.01% 2231
2018
Q3
$762K Buy
39,612
+4,563
+13% +$81.3K ﹤0.01% 2424
2018
Q2
$535K Buy
35,049
+1,297
+4% +$22.7K ﹤0.01% 2632
2018
Q1
$633K Buy
33,752
+7,989
+31% +$150K ﹤0.01% 2421
2017
Q4
$496K Sell
25,763
-455
-2% -$8.5K ﹤0.01% 2538
2017
Q3
$469K Buy
+26,218
New +$431K ﹤0.01% 2524

Other funds holding AMPH